| Trial registration number
|
NCT04739410 |
Full text link
Last imported at : Feb. 6, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
https://clinicaltrials.gov/show/NCT04739410
|
First author
Last imported at : Feb. 6, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Aijaz Zeeshan Khan Chachar
|
Contact
Last imported at : Feb. 6, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Not reported
|
Registration date
Last imported at : Feb. 6, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
2021-02-04
|
Recruitment status
Last imported at : Feb. 6, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Completed
|
Study design
Last imported at : Feb. 6, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
RCT
|
Allocation
Last imported at : Feb. 6, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Randomized
|
Design
Last imported at : Feb. 6, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Parallel
|
Masking
Last imported at : Feb. 6, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Open label
|
Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov
|
single-center
|
Study aim
Last imported at : Feb. 6, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Treatment
|
Inclusion criteria
Last imported at : Feb. 6, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
inclusion criteria:
- all patients diagnosed with covid-19 infection with positive reverse transcriptase
rt-pcr test, who were willing to participate in this study
- patients having age of 18-75 years
- patients of both genders male and female
- patients who had mild symptoms of corona virus disease and rt- pcr positive for
sars-cov-2
- ability to take oral medication and were willing to adhere to the drug intake regimen
|
Exclusion criteria
Last imported at : Feb. 6, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
- known severe allergic reactions to ivermectin
- pregnancy or breastfeeding
- severe symptoms likely attributed to cytokine release storm
- malignant diseases
- chronic kidney disease
- cirrhosis liver with child class b or c
|
Number of arms
Last imported at : Feb. 6, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
2
|
Funding
Last imported at : Feb. 6, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
FMH College of Medicine and Dentistry
|
Inclusion age min
Last imported at : Feb. 6, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
18
|
Inclusion age max
Last imported at : Feb. 6, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
75
|
Countries
Last imported at : Feb. 6, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Pakistan
|
Type of patients
Last imported at : Feb. 6, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Mild disease at enrollment
|
Severity scale
Last imported at : Feb. 6, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
1: Mild disease at enrollment
|
Total sample size
Last imported at : Feb. 6, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
50
|
primary outcome
Last imported at : Feb. 6, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Progression of the disease;Resolution of symptoms
|
Notes
Last imported at : Feb. 6, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
None
|
Phase
Last imported at : Feb. 25, 2021, 7:58 p.m.
Source : ClinicalTrials.gov
|
Phase 4
|
Arms
Last imported at : Feb. 6, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
[{"arm_notes": "", "treatment_id": 693, "treatment_name": "Ivermectin", "treatment_type": "Antiparasitics", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]
|